We are excited to announce that on September 3, 2024, the AFP PRO production facility was officially registered and approved by the US Food and Drug Administration (FDA). The successful completion of the registration process now allows us to introduce our products to the US market, known as one of the most competitive and demanding in the world.
FDA registration is not just a formality for selling products in the US; it also reflects our commitment to upholding the highest global quality standards. It’s a signal to our customers and business partners that they are collaborating with a company that constantly strives for excellence in production quality and compliance with international industry regulations.
We take pride in the fact that AFP PRO products are gaining recognition on a wider scale, and FDA registration is another important milestone in the execution of our growth strategy. This means we can better cater to the needs of global markets by providing products that meet the most stringent requirements.
